Literature DB >> 30060914

First rib fracture: A harbinger of severe trauma?

Robert E Luceri1, Nina E Glass2, Joanelle A Bailey1, Ziad C Sifri1, Anastasia Kunac1, Stephanie L Bonne1, Peter P Yonclas1, Anne C Mosenthal1, David H Livingston1.   

Abstract

BACKGROUND: Prior to routine CT scanning, first rib fractures (FRFs) were considered a harbinger of great vessel injuries. We hypothesized FRFs identified on screening CXR have significant associated injuries, while those identified on CT alone do not.
METHODS: We reviewed adult blunt thoracic trauma patients 2014-2015 to identify all FRFs and then tabulated demographics, injury characteristics, and outcomes.
RESULTS: Of 429 patients with chest trauma, 56 had a FRF. CXR diagnosed 20% and CT 80%. Those diagnosed on CXR were older (61 vs 48 p = 0.03), had more severe chest trauma (45% vs 13% chest AIS>3, p = 0.029), longer ICU stays (10 vs 4 days, p = 0.046), and risk for intubation (73% vs 27%, p = 0.011). There was only one major vascular injury in each group. Most FRF patients had associated injuries, including 82% with pelvic fractures.
CONCLUSIONS: Widespread use of CT scanning has resulted in a 5-fold increase in FRF diagnoses. While vascular injuries are not common, especially when identified on initial CXR, FRFs correlate with morbidity and associated injuries.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blunt trauma; First rib fracture; Vascular trauma

Mesh:

Year:  2018        PMID: 30060914     DOI: 10.1016/j.amjsurg.2018.07.034

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

Review 1.  Rib Fractures in Professional Baseball Pitchers: Mechanics, Epidemiology, and Management.

Authors:  Sean Schowalter; Bryan Le; James Creps; Kelly C McInnis
Journal:  Open Access J Sports Med       Date:  2022-10-10

2.  Automatic detection of rib fractures: Are we there yet?

Authors:  A Blum; R Gillet; A Urbaneja; P Gondim Teixeira
Journal:  EBioMedicine       Date:  2020-12-02       Impact factor: 8.143

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.